Traws Pharma, Inc. (NASDAQ: TRAW)
$5.0400
+0.0700 ( +1.41% ) 1.1K
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Market Data
Open
$5.0400
Previous close
$4.9700
Volume
1.1K
Market cap
$15.04M
Day range
$4.8710 - $5.1780
52 week range
$4.4400 - $24.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 22, 2024 |
| 8-k | 8K-related | 14 | May 16, 2024 |
| 10-q | Quarterly Reports | 64 | May 15, 2024 |
| 10-k/a | Quarterly Reports | 15 | Apr 29, 2024 |
| 8-k | 8K-related | 51 | Apr 16, 2024 |
| 3/a | Insider transactions | 1 | Apr 12, 2024 |
| 3/a | Insider transactions | 1 | Apr 11, 2024 |
| 8-k | 8K-related | 21 | Apr 04, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |